{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:09:35Z","timestamp":1779163775234,"version":"3.51.4"},"reference-count":34,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T00:00:00Z","timestamp":1464307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T00:00:00Z","timestamp":1464307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome Trust Strategic Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1111\/ane.12611","type":"journal-article","created":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T05:34:18Z","timestamp":1464327258000},"page":"73-79","source":"Crossref","is-referenced-by-count":39,"title":["Audit of use of stiripentol in adults with Dravet syndrome"],"prefix":"10.1155","volume":"135","author":[{"given":"S.","family":"Balestrini","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy; NIHR University College London Hospitals Biomedical Research Centre; UCL Institute of Neurology; London UK"},{"name":"Epilepsy Society; Chalfont-St-Peter Buckinghamshire UK"},{"name":"Neuroscience Department; Polytechnic University of Marche; Ancona Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Sisodiya","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy; NIHR University College London Hospitals Biomedical Research Centre; UCL Institute of Neurology; London UK"},{"name":"Epilepsy Society; Chalfont-St-Peter Buckinghamshire UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,5,27]]},"reference":[{"key":"10.1111\/ane.12611-BIB0001|ane12611-cit-0001","first-page":"89","volume-title":"Epileptic Syndromes in Infancy, Childhood and Adolescence","author":"Dravet","year":"2005","edition":"4"},{"key":"10.1111\/ane.12611-BIB0002|ane12611-cit-0002","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/brain\/awr129","article-title":"Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology","volume":"134","author":"Catarino","year":"2011","journal-title":"Brain"},{"key":"10.1111\/ane.12611-BIB0003|ane12611-cit-0003","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1528-1167.2010.02925.x","article-title":"Cognitive development in Dravet syndrome: a retrospective, multicenter study of 26 patients","volume":"52","author":"Ragona","year":"2011","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12611-BIB0004|ane12611-cit-0004","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/WNL.0b013e31820c309b","article-title":"Genotype-phenotype associations in SCN1A related epilepsies","volume":"76","author":"Zuberi","year":"2011","journal-title":"Neurology"},{"key":"10.1111\/ane.12611-BIB0005|ane12611-cit-0005","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1212\/01.wnl.0000249312.73155.7d","article-title":"Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults","volume":"67","author":"Jansen","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/ane.12611-BIB0006|ane12611-cit-0006","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1528-1167.2009.02466.x","article-title":"A long-term follow-up study of Dravet syndrome up to adulthood","volume":"51","author":"Akiyama","year":"2010","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12611-BIB0007|ane12611-cit-0007","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000326746","article-title":"Severe myoclonic epilepsy in infancy-adult phenotype with bradykinesia, hypomimia, and perseverative behavior: report of five cases","volume":"1","author":"Martin","year":"2010","journal-title":"Mol Syndromol"},{"issue":"Suppl. 2","key":"10.1111\/ane.12611-BIB0008|ane12611-cit-0008","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1528-1167.2011.03001.x","article-title":"Dravet syndrome: the long-term outcome","volume":"52","author":"Genton","year":"2011","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12611-BIB0009|ane12611-cit-0009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0387-7604(99)00113-8","article-title":"When antiepileptic drugs aggravate epilepsy","volume":"22","author":"Genton","year":"2000","journal-title":"Brain Dev"},{"key":"10.1111\/ane.12611-BIB0010|ane12611-cit-0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1528-1157.1998.tb01413.x","article-title":"Lamotrigine and seizure aggravation in severe myoclonic epilepsy","volume":"39","author":"Guerrini","year":"1998","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12611-BIB0011|ane12611-cit-0011","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/dmcn.12593","article-title":"Lamotrigine can be beneficial in patients with Dravet syndrome","volume":"57","author":"Dalic","year":"2015","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl. 2","key":"10.1111\/ane.12611-BIB0012|ane12611-cit-0012","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1528-1167.2011.03007.x","article-title":"The pharmacologic treatment of Dravet syndrome","volume":"52","author":"Chiron","year":"2011","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12611-BIB0013|ane12611-cit-0013","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1528-1167.2012.03495.x","article-title":"Successful use of fenfluramine as an add-on treatment for Dravet syndrome","volume":"53","author":"Ceulemans","year":"2012","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12611-BIB0014|ane12611-cit-0014","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0032-1307454","article-title":"Bromide in patients with SCN1A-mutations manifesting as Dravet syndrome","volume":"43","author":"Lotte","year":"2012","journal-title":"Neuropediatrics"},{"key":"10.1111\/ane.12611-BIB0015|ane12611-cit-0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eplepsyres.2014.10.014","article-title":"Efficacy and tolerability of the ketogenic diet in Dravet syndrome-comparison with various standard antiepileptic drug regimen","volume":"109","author":"Dressler","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12611-BIB0016|ane12611-cit-0016","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.yebeh.2013.08.037","article-title":"Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy","volume":"29","author":"Porter","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12611-BIB0017|ane12611-cit-0017","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group","volume":"356","author":"Chiron","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/ane.12611-BIB0018|ane12611-cit-0018","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/j.1528-1167.2009.02179.x","article-title":"Stiripentol open study in Japanese patients with Dravet syndrome","volume":"50","author":"Inoue","year":"2009","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12611-BIB0019|ane12611-cit-0019","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.eplepsyres.2014.02.008","article-title":"Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence","volume":"108","author":"Inoue","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12611-BIB0020|ane12611-cit-0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yebeh.2014.03.014","article-title":"Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam","volume":"34","author":"Strzelczyk","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12611-BIB0021|ane12611-cit-0021","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.eplepsyres.2015.03.012","article-title":"Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: a multicenter, open-label study in Japan","volume":"113","author":"Inoue","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12611-BIB0022|ane12611-cit-0022","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.eplepsyres.2014.03.009","article-title":"Reassessment of stiripentol pharmacokinetics in healthy adult volunteers","volume":"108","author":"Peign\u00e9","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12611-BIB0023|ane12611-cit-0023","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/bmj.305.6859.905","article-title":"Audit and research","volume":"305","author":"Smith","year":"1992","journal-title":"BMJ"},{"key":"10.1111\/ane.12611-BIB0024|ane12611-cit-0024","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1528-1157.1984.tb03448.x","article-title":"Michaelis-Menten kinetics of stiripentol in normal humans","volume":"25","author":"Levy","year":"1984","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12611-BIB0025|ane12611-cit-0025","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/FTD.0b013e31825dc4a6","article-title":"Concentrations of stiripentol in children and adults with epilepsy: the influence of dose, age, and comedication","volume":"34","author":"May","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1111\/ane.12611-BIB0026|ane12611-cit-0026","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ane.12403","article-title":"Stiripentol for the treatment of super-refractory status epilepticus","volume":"132","author":"Strzelczyk","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12611-BIB0027|ane12611-cit-0027","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2012.11.002","article-title":"Stiripentol is anticonvulsant by potentiating GABAergic transmission in a model of benzodiazepine-refractory status epilepticus","volume":"67","author":"Grosenbaugh","year":"2013","journal-title":"Neuropharmacology"},{"issue":"Suppl. 6","key":"10.1111\/ane.12611-BIB0028|ane12611-cit-0028","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/epi.12291","article-title":"Stiripentol in refractory status epilepticus","volume":"54","author":"Grosenbaugh","year":"2013","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12611-BIB0029|ane12611-cit-0029","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1528-1167.2006.00497.x","article-title":"Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA(A)-receptor channels","volume":"47","author":"Quilichini","year":"2006","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12611-BIB0030|ane12611-cit-0030","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2010.12.037","article-title":"Interactions between modulators of the GABA(A) receptor: stiripentol and benzodiazepines","volume":"654","author":"Fisher","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/ane.12611-BIB0031|ane12611-cit-0031","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/dmd.105.007237","article-title":"In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism","volume":"34","author":"Giraud","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/ane.12611-BIB0032|ane12611-cit-0032","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1528-1167.2007.01423.x","article-title":"Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data","volume":"49","author":"Kassa\u00ef","year":"2008","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12611-BIB0033|ane12611-cit-0033","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/epi.12303","article-title":"Stiripentol in Dravet syndrome: results of a retrospective U.S. study","volume":"54","author":"Wirrell","year":"2013","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12611-BIB0034|ane12611-cit-0034","unstructured":"National Institute for Health and Care Excellence The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care 2012 http:\/\/www.nice.org.uk\/guidance\/cg137"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12611","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12611","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12611\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T05:14:12Z","timestamp":1718601252000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12611","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5,27]]}}}